RPAM
ASTH icon

Rhenman & Partners Asset Management’s Astrana Health ASTH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.52M Buy
+118,888
New +$4.28M 0.52% 67
2025
Q3 		– Sell
-190,000
Closed -$4.73M – 103
2025
Q2 		$4.73M Buy
190,000
+40,000
+27% +$1.13M 0.6% 50
2025
Q1 		$4.65M Buy
150,000
+70,000
+88% +$2.33M 0.53% 47
2024
Q4 		$2.52M Buy
+80,000
New +$3.8M 0.26% 74

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Rhenman & Partners Asset Management's ASTH Position: Q2 2026 in Review

Rhenman & Partners Asset Management opened a new position in Astrana Health (ASTH) in Q2 2026: 118,888 shares worth $5.52M. The stake represents 0.52% of the portfolio and ranks #67 among its holdings. This is a return to the name: Rhenman & Partners Asset Management previously reported a position in ASTH as recently as Q2 2025.

Rhenman & Partners Asset Management first reported a position in ASTH in Q4 2024 and has held it in 4 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Rhenman & Partners Asset Management held 118,888 shares of Astrana Health worth $5.52M as of Q2 2026.
  • Astrana Health was a new Rhenman & Partners Asset Management position in Q2 2026.
  • Astrana Health made up 0.52% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #67 holding.
  • Rhenman & Partners Asset Management first reported a position in Astrana Health in Q4 2024 and has held it in 4 quarters since.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.